SERAF performs clinical addiction research that contributes to evidence-based treatment of addiction disorders.
We conduct extensive dissemination of addiction research through publications, lectures, courses, supervision and teaching of master's and PhD students.
SERAF has a broad national and international network in the field of clinical addiction research.
Rethinking ‘carriage’ of take-home naloxone
Apr. 15, 2021 3:37 PM
In a new article, SERAF researchers Desiree Eide and Thomas Clausen, in collaboration with King's College, suggest improvements to research methods regarding "take home" naloxone (THN).
In Norway naloxone nasal spray is distributed under the auspices of SERAF on behalf of the Norwegian Directorate of Health as part of a national overdose strategy ( Nalokson.org). Naloxone nasal spray is an antidote treatment for opioid overdose.
Somatic disease burdens among ageing, long-term opioid maintenance treatment patients
Nov. 19, 2020 10:14 AM
In a recently published article, researchers at SERAF and NIPH together with the user organization proLAR-Nett, have investigated the somatic disease burden for aging long-term patients in OMT.